Enanta Pharmaceuticals saw the highest growth of 199% in patent filings in February and 499% in grants in January in Q1 2024. Compared to Q4 2023, Q1 2024 saw an increase in patent filings by 24% and grants by 499%. GlobalData’s DataBook provides a comprehensive analysis of Enanta Pharmaceuticals‘s patent filings and grants. Buy the databook here.

Smarter leaders trust GlobalData

Enanta Pharmaceuticals has been focused on protecting inventions in United States(US) with five publications in Q1 2024

The United States(US) Patent Office dominates the patent grants with nearly 28% of grants. The Australia(AU), Israel(IL), United States(US), and South Korea(KR) patent Office are among the top ten patent offices where Enanta Pharmaceuticals is filings its patents. Among the top granted patent authorities, Enanta Pharmaceuticals has 28% of its grants in United States(US), 22% in South Korea(KR) and 17% in Israel(IL).

F. Hoffmann-La Roche and Johnson & Johnson could be the strongest competitors for Enanta Pharmaceuticals

Patents related to rare diseases and Covid-19 lead Enanta Pharmaceuticals's portfolio

Enanta Pharmaceuticals has the highest number of patents in rare diseases followed by, Covid-19 and climate change. For rare diseases, nearly 50% of patents were filed and 38% of patents were granted in Q1 2024.

Respiratory syncytial virus (rsv) infections related patents lead Enanta Pharmaceuticals portfolio followed by cardiovascular disease, and fatty liver disease

Enanta Pharmaceuticals has highest number of patents in respiratory syncytial virus (rsv) infections followed by cardiovascular disease, fatty liver disease, non alcoholic fatty liver disease (nafld), and non-alcoholic steatohepatitis (nash).

For comprehensive analysis of Enanta Pharmaceuticals's filings and grants, buy the databook here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.

Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.